Since several reports demonstrated that IL-6 enhances the migration ability and invasiveness of gastric and colon cancer cells [8,12,20,23,24,33], we investigated the effect of the treatment with rIL-6 on either migration or invasive ability in human primary T88 and T93 colon cancer cells. The gene discussed is IL6; the disease is colonic neoplasm.